FALCON POWERS – The Gamaleya Center in Russia is currently conducting preclinical trials on a revolutionary cancer vaccine. Will this vaccine treat one of the most well-known diseases of our time?
In a recent press interview, Russian academic and center director Alexander Gintsburg answered some questions about the anticipated vaccine.
How will the vaccine work?
Gintsburg explained, “Our cancer vaccine is a therapeutic one, meaning it is designed for people who already have cancer. We call it a ‘vaccine’ because it is designed to activate our immune system – to make our lymphocytes recognize and destroy the cancer cells. A personalized vaccine will be produced for each patient, using the same technology. Doctors will take samples of the tumor and healthy cells, researchers will compare them to identify the mutated parts, and these specific parts will form the basis of the vaccine. Once introduced into the body, they will attract the attention of the lymphocytes, which will destroy the injected cells and remember them, then start fighting the cancer cells.”
He noted that this process has been successfully tested on laboratory animals, indicating this method is promising.
Where will the vaccine be injected?
Gintsburg explained that the vaccine will not be administered intravenously, as the formulation would then go to the liver and be ineffective. Instead, it is best to inject it directly into the tumor, if the doctors can access it, or into the muscle. Studies have shown this method helps distribute the drug evenly throughout the body, making it effective.
